Agenus (AGEN) Interest Expenses (2010 - 2026)
Agenus' (AGEN) quarterly Interest Expenses came in at $14.7 million in Q1 2026, up 13.15% year-on-year from $13.0 million in Q1 2025, and down 8.47% quarter-over-quarter from $16.0 million in Q4 2025.
Agenus (AGEN) Interest Expenses (2010 - 2026) Analysis & Trends
Agenus' Interest Expenses history runs 17 years deep, the most recent figure standing at $14.7 million for Q1 2026.
- On a quarterly basis, Interest Expenses rose 13.15% year-over-year to $14.7 million in Q1 2026; TTM through Mar 2026 was $57.1 million, a 44.67% decrease from a year earlier, with the FY2025 full-year figure at $395.3 million, down 1.55% from the prior year.
- Interest Expenses fell to $14.7 million in Q1 2026 per AGEN's latest filing, from $16.0 million in the prior quarter.
- Across five years, Interest Expenses topped out at $36.7 million in Q3 2024 and bottomed at $296000.0 in Q4 2022.
- The 5-year median for Interest Expenses is $2.4 million (2025), against an average of $10.9 million.
- Across the five-year window, Interest Expenses tumbled 99.06% in 2022 and soared 9087.0% in 2024, its largest moves.
- Year by year, Interest Expenses stood at $296000.0 in 2022, then surged by 114.86% to $636000.0 in 2023, then jumped by 3219.97% to $21.1 million in 2024, then retreated by 23.99% to $16.0 million in 2025, then retreated by 8.47% to $14.7 million in 2026.
- Per Business Quant, the three latest AGEN Interest Expenses figures stand at $14.7 million (Q1 2026), $16.0 million (Q4 2025), and $2.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | Agenus | 222.90 Mn | 222.90 Mn | 33.74 Mn | 14.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.69 Mn |
| Mar 31, 2026 | 14.69 Mn |
| Dec 31, 2025 | 16.05 Mn |
| Dec 31, 2025 | 16.05 Mn |
| Sep 30, 2025 | 2.43 Mn |
| Sep 30, 2025 | 2.43 Mn |
| Jun 30, 2025 | 13.34 Mn |
| Jun 30, 2025 | 13.34 Mn |
| Mar 31, 2025 | 12.98 Mn |
| Mar 31, 2025 | 12.98 Mn |
| Dec 31, 2024 | 21.12 Mn |
| Dec 31, 2024 | 21.12 Mn |
| Sep 30, 2024 | 36.75 Mn |
| Sep 30, 2024 | 36.75 Mn |
| Jun 30, 2024 | 32.28 Mn |
| Jun 30, 2024 | 32.28 Mn |
| Mar 31, 2024 | 30.27 Mn |
| Mar 31, 2024 | 30.27 Mn |
| Dec 31, 2023 | 636,000.00 |
| Dec 31, 2023 | 636,000.00 |